{{Rsnum
|rsid=1169286
|Gene=HNF1A
|Chromosome=12
|position=120981253
|Orientation=minus
|GMAF=0.433
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=HNF1A
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.9 | 45.1 | 15.9
| HCB | 27.2 | 54.4 | 18.4
| JPT | 11.5 | 55.8 | 32.7
| YRI | 68.7 | 29.3 | 2.0
| ASW | 51.8 | 46.4 | 1.8
| CHB | 27.2 | 54.4 | 18.4
| CHD | 37.6 | 45.9 | 16.5
| GIH | 27.7 | 45.5 | 26.7
| LWK | 53.6 | 39.1 | 7.3
| MEX | 10.3 | 37.9 | 51.7
| MKK | 59.6 | 35.9 | 4.5
| TSI | 31.4 | 48.0 | 20.6
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs1169286
|Name_s=
|Gene_s=TCF1
|Feature=Intron
|Evidence=PubMed ID:18439552
|Annotation=In a candidate gene-based association analysis of 4333 European-descended, age 65 or older, subjects from the CHS study (Cardiovascular Health Study), this was one of the SNPs most strongly associated with plasma C-reactive protein levels. The minor allele is part of a haplotype of frequency 30% which was associated with lower levels of CRP.
|Drugs=
|Drug Classes=
|Diseases=Cardiovascular Diseases
|Curation Level=Curated
|PharmGKB Accession ID=PA162399846
}}

{{PMID Auto
|PMID=21647738
|Title=Genome-wide association with C-reactive protein levels in CLHNS: evidence for the CRP and HNF1A loci and their interaction with exposure to a pathogenic environment.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1169286
|overall_frequency_n=48
|overall_frequency_d=128
|overall_frequency=0.375
|n_genomes=32
|n_genomes_annotated=0
|n_haplomes=41
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}